Avoro Capital Advisors LLC Black Diamond Therapeutics, Inc. Transaction History

Avoro Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.19 - $28.17 $5.36 Million - $12.4 Million	-440,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$22.23 - $34.75 $4.45 Million - $6.95 Million	-200,000 Reduced 31.25%	440,000 $10.7 Million
Q4 2020 Feb 16, 2021	BUY	$29.47 - $35.0 $1.11 Million - $1.31 Million	37,500 Added 6.22%	640,000 $20.5 Million
Q3 2020 Nov 16, 2020	BUY	$26.17 - $43.07 $2.03 Million - $3.34 Million	77,500 Added 14.76%	602,500 $18.2 Million
Q2 2020 Aug 14, 2020	BUY	$22.3 - $44.8 $72,475 - $145,600	3,250 Added 0.62%	525,000 $22.1 Million
Q1 2020 May 15, 2020	BUY	$18.18 - $39.48 $9.49 Million - $20.6 Million	521,750 New	521,750 $13 Million

121

48.8M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $89.4M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.